OEV Partners is a new kind of consultancy – purposely built to support and serve the emerging new industries, fresh thinking and revolutionary mental health treatments now made possible by global drug-law reform.
We believe that new treatments using psilocybin, MDMA, LSD, ibogaine and ketamine, will soon be as indispensable in mental healthcare as anaesthetic or antibiotics are in surgery – and so do increasing numbers of lawmakers, medics, and investors worldwide.
As outdated policies are uprooted and rightly discarded, our goal is to help this dynamic and complex sector grow – responsibly.
That means the needs of patients first – in everything we do, from advocacy and campaigning to education, continuous improvement and service design